Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Verrica Pharmaceuticals Inc. | 176,458 | reported | 17 Mar 2025 | tx 22+1,090,714−129,256 |
1 purchase reported after at least 12 months of silence — most recent on 05 Jul 2022.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Mar 2025 | SALE | Verrica Pharmaceuticals Inc. | 4,315 | 0.65 USD | |
| 14 Mar 2025 | GRANT_AWARD | Verrica Pharmaceuticals Inc. | 250,000 | 0.00 USD | deriv |
| 09 Oct 2024 | GRANT_AWARD | Verrica Pharmaceuticals Inc. | 50,000 | 0.00 USD | deriv |
| 26 Aug 2024 | SALE | Verrica Pharmaceuticals Inc. | 26,183 | 2.66 USD | |
| 27 Aug 2024 | SALE | Verrica Pharmaceuticals Inc. | 9,530 | 2.46 USD | |
| 23 Jul 2024 | SALE | Verrica Pharmaceuticals Inc. | 91 | 6.98 USD | |
| 22 Jul 2024 | SALE | Verrica Pharmaceuticals Inc. | 21,649 | 7.06 USD | |
| 15 Mar 2024 | GRANT_AWARD | Verrica Pharmaceuticals Inc. | 40,000 | 0.00 USD | |
| 15 Mar 2024 | GRANT_AWARD | Verrica Pharmaceuticals Inc. | 80,000 | 0.00 USD | deriv |
| 14 Nov 2023 | SALE | Verrica Pharmaceuticals Inc. | 22,141 | 2.93 USD | |
| 15 Nov 2023 | SALE | Verrica Pharmaceuticals Inc. | 11,558 | 2.97 USD | |
| 24 Aug 2023 | GRANT_AWARD | Verrica Pharmaceuticals Inc. | 75,000 | 0.00 USD | |
| 21 Jul 2023 | GRANT_AWARD | Verrica Pharmaceuticals Inc. | 100,000 | 0.00 USD | |
| 24 Jul 2023 | SALE | Verrica Pharmaceuticals Inc. | 33,789 | 4.83 USD | |
| 01 Mar 2023 | GRANT_AWARD | Verrica Pharmaceuticals Inc. | 135,000 | 0.00 USD | deriv |
| 11 Jul 2022 | PURCHASE | Verrica Pharmaceuticals Inc. | 7,500 | 3.40 USD | |
| 05 Jul 2022 | PURCHASE | Verrica Pharmaceuticals Inc. | 5,714 | 2.10 USD | first after silence |
| 24 Feb 2022 | GRANT_AWARD | Verrica Pharmaceuticals Inc. | 75,000 | 0.00 USD | deriv |
| 04 Jun 2021 | PURCHASE | Verrica Pharmaceuticals Inc. | 2,500 | 9.79 USD | |
| 01 Mar 2021 | GRANT_AWARD | Verrica Pharmaceuticals Inc. | 65,000 | 0.00 USD | deriv |
| 27 Feb 2020 | GRANT_AWARD | Verrica Pharmaceuticals Inc. | 55,000 | 0.00 USD | deriv |